- Home
- ENZ vs CTXR Comparison
ENZ vs CTXR Comparison
Compare ENZ & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- CTXR
- Stock Information
- Founded
- ENZ 1976
- CTXR 2007
- Country
- ENZ United States
- CTXR United States
- Employees
- ENZ N/A
- CTXR N/A
- Industry
- ENZ Medical Specialities
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- ENZ Health Care
- CTXR Health Care
- Exchange
- ENZ Nasdaq
- CTXR Nasdaq
- Market Cap
- ENZ 34.2M
- CTXR 28.4M
- IPO Year
- ENZ N/A
- CTXR N/A
- Fundamental
- Price
- ENZ $0.66
- CTXR $3.30
- Analyst Decision
- ENZ
- CTXR Strong Buy
- Analyst Count
- ENZ 0
- CTXR 2
- Target Price
- ENZ N/A
- CTXR $54.50
- AVG Volume (30 Days)
- ENZ 154.0K
- CTXR 185.5K
- Earning Date
- ENZ 03-12-2025
- CTXR 02-12-2025
- Dividend Yield
- ENZ 61.07%
- CTXR N/A
- EPS Growth
- ENZ N/A
- CTXR N/A
- EPS
- ENZ N/A
- CTXR N/A
- Revenue
- ENZ $30,314,000.00
- CTXR N/A
- Revenue This Year
- ENZ N/A
- CTXR N/A
- Revenue Next Year
- ENZ N/A
- CTXR $216.25
- P/E Ratio
- ENZ N/A
- CTXR N/A
- Revenue Growth
- ENZ N/A
- CTXR N/A
- 52 Week Low
- ENZ $0.63
- CTXR $2.44
- 52 Week High
- ENZ $1.41
- CTXR $26.75
- Technical
- Relative Strength Index (RSI)
- ENZ 31.11
- CTXR 41.54
- Support Level
- ENZ $0.63
- CTXR $3.70
- Resistance Level
- ENZ $0.72
- CTXR $4.43
- Average True Range (ATR)
- ENZ 0.04
- CTXR 0.54
- MACD
- ENZ 0.01
- CTXR 0.06
- Stochastic Oscillator
- ENZ 19.23
- CTXR 6.03
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.